Literature DB >> 10872589

Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction.

K Fukuda1, L Guo, N Ohashi, M Yoshikawa, Y Yamazoe.   

Abstract

A method for the determination of three furocoumarins containing two new chemicals (GF-I-1 and GF-I-4) in commercially available grapefruit juice and grapefruit itself was developed using high-performance liquid chromatography (HPLC). These components isolated from grapefruit juice have 5-geranyloxyfurocoumarin dimer structures showing extremely high affinities for a form of cytochrome P450 (CYP3A4). Considerable differences were observed on the contents among commercial brands and also batches. The contents were determined to be 321.4+/-95.2 ng/ml GF-I-1, 5641.2+/-1538.1 ng/ml GF-I-2 and 296.3+/-84.9 ng/ml GF-I-4 in twenty-eight white grapefruit juices. These chemicals were not detected in beverages from orange, apple, grape and tangerine, except that trace amount of GF-I-2 and GF-I-4 were found in lemon juice. The average levels of these furocoumarins were lower in the juice from red grapefruit than a white one. The highest level of these components were found in the fruit meat.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872589     DOI: 10.1016/s0378-4347(00)00104-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  9 in total

Review 1.  Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

2.  Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition.

Authors:  Ute I Schwarz; Philip E Johnston; David G Bailey; Richard B Kim; Gail Mayo; Aaron Milstone
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

3.  The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women.

Authors:  Kristine R Monroe; Frank Z Stanczyk; Kathleen H Besinque; Malcolm C Pike
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

4.  Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.

Authors:  Christopher Banfield; Samir Gupta; Mark Marino; Josephine Lim; Melton Affrime
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.

Authors:  H Wangensteen; E Molden; H Christensen; K E Malterud
Journal:  Eur J Clin Pharmacol       Date:  2003-01-30       Impact factor: 2.953

6.  Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults.

Authors:  Ronald de Vries; Johan W Smit; Peter Hellemans; James Jiao; Joseph Murphy; Donna Skee; Jan Snoeys; Juthamas Sukbuntherng; Maarten Vliegen; Loeckie de Zwart; Erik Mannaert; Jan de Jong
Journal:  Br J Clin Pharmacol       Date:  2016-01-15       Impact factor: 4.335

7.  Rapid Quantitation of Furanocoumarins and Flavonoids in Grapefruit Juice using Ultra-Performance Liquid Chromatography.

Authors:  Karen M Vandermolen; Nadja B Cech; Mary F Paine; Nicholas H Oberlies
Journal:  Phytochem Anal       Date:  2013-06-18       Impact factor: 3.373

8.  Differences in the Perception of Dietary Supplements between Dietary Supplement/Medicine Users and Non-Users.

Authors:  Tsuyoshi Chiba; Nanae Tanemura
Journal:  Nutrients       Date:  2022-10-03       Impact factor: 6.706

Review 9.  Chemistry and health effects of furanocoumarins in grapefruit.

Authors:  Wei-Lun Hung; Joon Hyuk Suh; Yu Wang
Journal:  J Food Drug Anal       Date:  2016-12-06       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.